• Something wrong with this record ?

ADMET parameters of tacrine and its metabolites confirm unsuitability of Sus scrofa f. domestica model to study tacrine-associated hepatotoxicity

M. Novak, J. Bureš, V. Radochová, J. Pejchal, L. Prchal, O. Soukup

. 2025 ; 416 (-) : 111548. [pub] 20250503

Language English Country Ireland

Document type Journal Article

Tacrine, the first approved drug against Alzheimer's disease (AD), was withdrawn from clinical use due to serious adverse effects. The main concern was the human hepatotoxicity, stemming probably from the liver biotransformation and clinically manifested as hepatocellular necrosis, and lobular hepatitis. Concerning the biotransformation, 7-OH-tacrine metabolite is generally suspected of being a precursor of toxic quinone methide, which binds to intracellular -SH proteins and/or depletes intracellular glutathione, and by that probably causes the hepatotoxicity. However, to study these toxic effects, proper animal model is needed to monitor the interspecies differences of metabolism. To fully describe in vivo ADMET parameters of tacrine, five experimental pigs (Sus scrofa f. domestica), as the most physiologically human-like in vivo model showing similar tacrine biotransformation, were used. We studied tacrine and its metabolites ADMET characteristics after both acute i.g. single dose and chronic 42 days p.o daily dose administration of 200 mg of tacrine. Tacrine and its two major metabolites show Tmax in plasma of 360 min, so the absorption is much slower than in human (Tmax = 120 min) and are primarily distributed to the gastro-intestinal tract and CNS. Furthermore, due to the lower activity of CYP1A2 in pigs, tacrine is biotransformed much less efficiently than in humans. This study showed that tacrine accumulates only in adipose tissue, and organ histology and plasma biochemistry assessment revealed no signs of hepatotoxicity even after chronic tacrine administration. Pigs are therefore an unsuitable human-like animal model for evaluating tacrine toxicity.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25015132
003      
CZ-PrNML
005      
20250731090759.0
007      
ta
008      
250708e20250503ie f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.cbi.2025.111548 $2 doi
035    __
$a (PubMed)40319996
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ie
100    1_
$a Novak, M $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 50005, Hradec Kralove, Czech Republic
245    10
$a ADMET parameters of tacrine and its metabolites confirm unsuitability of Sus scrofa f. domestica model to study tacrine-associated hepatotoxicity / $c M. Novak, J. Bureš, V. Radochová, J. Pejchal, L. Prchal, O. Soukup
520    9_
$a Tacrine, the first approved drug against Alzheimer's disease (AD), was withdrawn from clinical use due to serious adverse effects. The main concern was the human hepatotoxicity, stemming probably from the liver biotransformation and clinically manifested as hepatocellular necrosis, and lobular hepatitis. Concerning the biotransformation, 7-OH-tacrine metabolite is generally suspected of being a precursor of toxic quinone methide, which binds to intracellular -SH proteins and/or depletes intracellular glutathione, and by that probably causes the hepatotoxicity. However, to study these toxic effects, proper animal model is needed to monitor the interspecies differences of metabolism. To fully describe in vivo ADMET parameters of tacrine, five experimental pigs (Sus scrofa f. domestica), as the most physiologically human-like in vivo model showing similar tacrine biotransformation, were used. We studied tacrine and its metabolites ADMET characteristics after both acute i.g. single dose and chronic 42 days p.o daily dose administration of 200 mg of tacrine. Tacrine and its two major metabolites show Tmax in plasma of 360 min, so the absorption is much slower than in human (Tmax = 120 min) and are primarily distributed to the gastro-intestinal tract and CNS. Furthermore, due to the lower activity of CYP1A2 in pigs, tacrine is biotransformed much less efficiently than in humans. This study showed that tacrine accumulates only in adipose tissue, and organ histology and plasma biochemistry assessment revealed no signs of hepatotoxicity even after chronic tacrine administration. Pigs are therefore an unsuitable human-like animal model for evaluating tacrine toxicity.
650    _2
$a zvířata $7 D000818
650    12
$a takrin $x farmakokinetika $x toxicita $x metabolismus $x analogy a deriváty $7 D013619
650    12
$a játra $x účinky léků $x metabolismus $x patologie $7 D008099
650    _2
$a prasata $7 D013552
650    _2
$a Sus scrofa $7 D034421
650    _2
$a mužské pohlaví $7 D008297
650    12
$a lékové postižení jater $x metabolismus $x patologie $7 D056486
650    _2
$a biotransformace $7 D001711
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a cholinesterasové inhibitory $x toxicita $x farmakokinetika $7 D002800
650    _2
$a lidé $7 D006801
655    _2
$a časopisecké články $7 D016428
700    1_
$a Bureš, J $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 50005, Hradec Kralove, Czech Republic
700    1_
$a Radochová, V $u Vivarium, Military Faculty of Medicine, University of Defence, Trebeska 1575, 50005, Hradec Kralove, Czech Republic
700    1_
$a Pejchal, J $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 50005, Hradec Kralove, Czech Republic; Department of Toxicology and Military Pharmacy, Military Faculty of Medicine, University of Defence, Trebeska 1575, 50005, Hradec Kralove, Czech Republic
700    1_
$a Prchal, L $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 50005, Hradec Kralove, Czech Republic
700    1_
$a Soukup, O $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 50005, Hradec Kralove, Czech Republic. Electronic address: ondrej.soukup@fnhk.cz
773    0_
$w MED00002111 $t Chemico-biological interactions $x 1872-7786 $g Roč. 416 (20250503), s. 111548
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40319996 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250708 $b ABA008
991    __
$a 20250731090753 $b ABA008
999    __
$a ok $b bmc $g 2366166 $s 1252257
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 416 $c - $d 111548 $e 20250503 $i 1872-7786 $m Chemico-biological interactions $n Chem Biol Interact $x MED00002111
LZP    __
$a Pubmed-20250708

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...